MUSTANG BIO, INC. Notes Payable
MUSTANG BIO, INC. (MBIO) had Notes Payable of $13.96 million as of 2020-06-30, per its 10-Q filed 2020-08-10.
Discontinued › Balance Sheet › Liabilities
us-gaap:NotesPayable · last filed 2020-08-10
- 2020-06-30: Notes Payable $13.96M.
- 2020-03-31: Notes Payable $13.69M.
- 2019-12-31: Notes Payable $13.43M.
- 2019-09-30: Notes Payable $13.19M.
| Period end | Notes Payable |
|---|---|
| 2020-06-30 | $13.96M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $13.69M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $13.43M 10-Q · filed 2020-08-10 |
| 2019-09-30 | $13.19M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $12.95M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $12.72M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-16 |
| 2016-09-30 | $2.93M 10-Q · filed 2016-11-14 |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |